Antigen-specific CD8 + autologous T lymphocytes can identify MDM2, and its epitopes can serve as a TAA to activate cytotoxic T lymphocytes (CTLs) that can eliminate tumor cells expressing MDM2 [11, 33]. The gene discussed is CD8A; the disease is neoplasm.